# Octapharma Plasma Inc – FDA Inspection, May 4, 2018

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/a9e02f54-35cc-4f5c-bc3c-31b926113291
Source feed: FDA_Inspections

> FDA inspection 1050669 of Octapharma Plasma Inc, May 04, 2018. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 640. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1050669
- Company Name: Octapharma Plasma Inc
- Inspection Date: 2018-05-04
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 1149614 - 2021-07-29
- [FDA Inspection 956003 - 2016-01-19](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/2c3ae100-3938-4970-874c-98dec7a7f87a)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/kathleen-b-swat/8bbaa25d-cf50-4da5-8b6c-ce32df24e978)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/d0081d27-b2af-40bb-b085-5b215f94e8a6

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d